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Huntington disease (HD) is caused by an expansion of more
than 35– 40 polyglutamine (polyQ) repeats in the huntingtin
(htt) protein, resulting in accumulation of inclusion bodies containing fibrillar deposits of mutant htt fragments. Intriguingly,
polyQ length is directly proportional to the propensity for htt to
form fibrils and the severity of HD and is inversely correlated
with age of onset. Although the structural basis for htt toxicity is
unclear, the formation, abundance, and/or persistence of toxic
conformers mediating neuronal dysfunction and degeneration
in HD must also depend on polyQ length. Here we used atomic
force microscopy to demonstrate mutant htt fragments and synthetic polyQ peptides form oligomers in a polyQ length-dependent
manner. By time-lapse atomic force microscopy, oligomers form
before fibrils, are transient in nature, and are occasionally direct
precursors to fibrils. However, the vast majority of fibrils appear to
form by monomer addition coinciding with the disappearance of
oligomers. Thus, oligomers must undergo a major structural transition preceding fibril formation. In an immortalized striatal cell
line and in brain homogenates from a mouse model of HD, a
mutant htt fragment formed oligomers in a polyQ length-dependent manner that were similar in size to those formed in vitro,
although these structures accumulated over time in vivo. Finally,
using immunoelectron microscopy, we detected oligomeric-like
structures in human HD brains. These results demonstrate that
oligomer formation by a mutant htt fragment is strongly polyQ
length-dependent in vitro and in vivo, consistent with a causative
role for these structures, or subsets of these structures, in HD
pathogenesis.

Huntington disease (HD),3 a fatal neurodegenerative disorder, is caused by an expansion of a polyglutamine (polyQ)
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repeat in the protein huntingtin (htt) (1). This expanded polyQ
domain mediates the deposition of cytoplasmic and intranuclear inclusion bodies that contain fibrillar material as determined by electron microscopy of HD brain tissues (2). PolyQ
expansions are also responsible for a growing number of less
common neurodegenerative disorders, such as the spinocerebellar ataxias (3). One of the most fascinating aspects of polyQ
diseases is that the age of onset and severity of disease are tightly
correlated with the length of the polyQ expansion. For example,
HD repeat lengths of fewer than 35 do not result in disease,
35–39 repeats may or may not cause disease, 40 – 60 repeats
elicits adult onset HD, and more than 60 repeats results in juvenile forms of HD (4 – 6).
Biochemical analyses of purified mutant htt fragments with
polyQ repeats longer than 39Q demonstrated the polyQ lengthdependent formation of detergent-insoluble protein aggregates
characteristic of amyloid fibrils (7, 8). Synthetic polyQ peptides
with expanded polyQ repeats also form amyloid-like fibrils, but
surprisingly, in contrast to studies with htt exon 1, synthetic
peptides with non-disease-causing polyQ lengths readily aggregated into fibrils (9). In cell culture, mutant htt fragments form
intranuclear and cytoplasmic inclusion bodies in a polyQ
length-dependent manner (10 –12). Thus, polyQ length
directly correlates with the kinetics of aggregation into fibrils
and formation of inclusion bodies. Mutant htt fragments and
other expanded polyQ proteins, as demonstrated with transmission electron microscopy and atomic force microscopy
(AFM), also assemble into spherical and annular oligomeric
structures similar in size and morphology to those formed by
A␤, ␣-synuclein, and other proteins that have been implicated
in neurodegeneration (13–15). However, whether or not such
structures form in a polyQ length-dependent manner has not
been rigorously established.
Although inclusion bodies are a major neuropathological
hallmark of HD (3), whether or not intraneuronal aggregates
mediate HD pathogenesis is still not resolved. Considering the
direct correlation between mutant htt aggregation and severity
of pathogenesis with polyQ length (7), aggregation was thought
to be causative in neurodegeneration. However, how the misglutamine repeats; HD46Q, mutant htt fragment with 46 glutamine
repeats; HD53Q, mutant htt fragment with 53 glutamine repeats; GST, glutathione S-transferase; AGE, agarose gel electrophoresis; EM, immunoelectron microscopy; GFP, green fluorescent protein.
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folded/aggregated form(s) mediates pathogenesis is unclear.
Although, the onset of symptoms trails inclusion body formation in a transgenic mouse model of HD (16), it might also be a
conserved cellular mechanism to protect against diffuse, soluble, toxic forms of mutant htt (11, 17, 18). Indeed, such soluble
aggregates that precede symptoms may exist (19). In agreement
with this hypothesis, a stable, toxic, monomeric ␤-sheet conformation of a thioredoxin-polyQ fusion protein was recently
reported (20), suggesting that polyQ adopts multiple, distinct
conformations that may have toxic consequences even in the
absence of higher order aggregation. However, a mutant htt
fragment may also misfold into distinct amyloid conformations
and, depending on whether the polyQ domain was exposed or
buried in a ␤-sheet, the amyloids can be either toxic or nontoxic, respectively (21). Our recent studies used AFM and other
techniques to show that an expanded polyQ domain in a
mutant htt fragment adopts a stable multitude of monomeric
(22) and oligomeric4 conformations that can readily be discriminated by monoclonal antibodies in vitro and in situ (22).4
Because polyQ length only above a critical threshold (35–
40Q) causes HD and is correlated to the onset and severity of
the disease, the formation, abundance, and/or persistence of
toxic conformers that mediate neuronal dysfunction and
degeneration in HD must also be polyQ length-dependent.
Here, we sought to systematically quantify the effects of polyQ
length on the kinetics, morphologies, and abundance of aggregates formed by a mutant htt fragment in comparison to those
formed by synthetic peptides. Because traditional light and
electron microscopic approaches have important limitations
for studying heterogeneous mixtures of htt aggregates, we used
AFM to characterize the morphology of the assembly states.
AFM is uniquely well suited to study amyloidogenic proteins. It
yields three-dimensional surface maps with nanometer resolution in solution in the absence of artifacts from sample processing. Our aim was to determine the precise relationship between
aggregate morphology, kinetics of formation, and polyQ length.

EXPERIMENTAL PROCEDURES
Protein Purification—Glutathione S-transferase (GST)-HD
fusion proteins were purified as described (24). Cleavage of the
GST moiety by a PreScission Protease (GE Healthcare) initiates
aggregation. Fresh, unfrozen GST-HD fusion protein was used for
each experiment. Solutions with all fusion proteins were centrifuged at 20,000 ⫻ g for 30 min at 4 °C to remove any preexisting
aggregates before the addition of the PreScission protease.
Peptide Preparation—All peptides were custom synthesized
and obtained from 21st Century Biochemicals (Marlboro, MA).
The flanking lysines were included to ensure solubility. Disaggregation and solubilization of polyQ peptides were performed
as described (25). Briefly, peptides were dissolved in a 50:50
mixture of trifluoroacetic acid and hexafluoroisopropanol.
After vortexing, the solution was incubated at room temperature for 30 min with agitation. The solvent was then evaporated
off. The remaining peptide residue was resuspended in water
adjusted to pH 3 with trifluoroacetic acid and to a concentra4

E. J. Mitchell, G. Lotz, B. Apostol, A. Weiss, G. P. Bates, P. Paganetti, P. J.
Muchowski, C. Glabe, and L. M. Thompson, manuscript in preparation.
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tion of 0.5 mg/ml. This was in turn diluted into Buffer A (50 mM
Tris-HCl, pH 7, 150 mM NaCl).
Atomic Force Microscopy—For experiments on monomeric
preparations of mutant htt proteins, GST-HD fusion proteins
were incubated at 30 and 2 M with 1 mM dithiothreitol (DTT)
or at 60 M without DTT in buffer A (50 mM Tris-HCl, pH 7,
150 mM NaCl). PreScission protease (4 units of 100 g of fusion
protein) was added at time 0 to initiate GST cleavage and aggregation. Samples were incubated at 37 °C and 1400 rpm for the
duration of the experiment. At 1, 3, 5, 8, and 24 h after cleavage
of the GST, a sample (5 l) of each incubation solution was
deposited on freshly cleaved mica (Ted Pella Inc., Redding, CA)
and allowed to sit for 30 s. Then the substrate was washed with
200 l of ultrapure water and dried under a gentle steam of air.
For experiments on preformed fibrils, 40 M solutions of
HD53Q were incubated without DTT for 5– 6 h after the
removal of the GST tag to allow the formation of fibrils.
Each sample was imaged ex situ using a MFP3D scanning
probe microscope (Asylum Research, Santa Barbara, CA).
Images were taken with silicon cantilever with a nominal spring
constant of 40 newtons/m and resonance frequency of ⬃ 300
kHz. Typical imaging parameters were drive amplitude, 150 –
500 kHz with set points of 0.7– 0.8 V, scan frequencies of 2– 4
Hz, image resolution 512 by 512 points, and scan size of 5 m.
All experiments were performed in triplicate.
For in situ AFM experiments tracking aggregation of monomeric preparations of HD53Q or synthetic peptide, bare substrate was imaged in buffer A, and the sample was injected
directly into the fluid cell to reach the final concentration for
the experiment. For in situ AFM experiments of preformed
HD53Q fibrils, solutions containing preformed fibrils of
HD53Q were allowed to rest on mica until several fibrils were
present on the surface. Then the substrate was washed with
buffer A to remove proteins remaining in solution, and then
fresh monomeric preparations of HD53Q that had been incubated with protease on ice for 1 h was injected directly into the
fluid cell. All in situ AFM images were taken with V-shaped
oxide-sharpened silicon nitride cantilever with a nominal
spring constant of 0.5 newtons/m. Scan rates were set at 1–2 Hz
with cantilever drive frequencies ranging from ⬃8 to 12 kHz.
Images were taken with an image resolution of 1024 by 1024
points with scan sizes ranging from 10 to 20 m. Image analysis
of all AFM images was performed with Matlab with the image
processing toolbox (Mathworks, Natick, MA) (for more details,
see the supplemental material). Volume measurements were
partially corrected for error associated with the finite size of the
AFM probe based on geometric models (26).
SDS-Agarose Gel Electrophoresis (SDS-AGE) of Purified Mutant Htt Fragments—The analysis of mutant htt fragments by
SDS-AGE with Western analysis was performed as described
(19). Mutant htt oligomers were resolved by immunoreactions
with the EM48 antibody (Chemicon, MAB5374). HD20Q and
HD53Q proteins were purified as described (15, 24). Fresh,
unfrozen HD53Q and HD20Q proteins were used for all experiments. Before each experiment, HD20Q or HD53Q was centrifuged (20,000 ⫻ g) for 30 min at 4 °C to remove pre-existing
aggregates. HD20Q or HD53Q were incubated at 12 M in 20
mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM DTT at 37 °C with
VOLUME 285 • NUMBER 19 • MAY 7, 2010
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shaking at 800 rpm. Solutions of PreScission Protease (4 units/
100 g of fusion protein, Amersham Biosciences) were added at
time 0 to initiate the aggregation of HD53Q. At the indicated
time points after GST cleavage, equal amounts of protein (15
g) were removed from the 12 M aggregation reactions,
diluted 1:1 into non-reducing Laemmli sample buffer (150 mM
Tris-HCl, pH 6.8, 33% glycerol, 1.2% SDS, and bromphenol
blue), and analyzed by SDS-AGE and Western analysis with
EM48 (1:1000). Molecular mass standards used in SDS-AGE
were ferritin (400 kDa), thyroglobulin (660 kDa), and IgM (1000
kDa).
SDS-AGE of ST14A Cell Homogenates—Complete Httex1p
plasmids encoding either a normal range (25Q), intermediate
(46Q), or expanded (97Q) polyQ tract with alternating CAG/
CAA amino acid repeats were fused in-frame to GFP at the C
terminus and subcloned into pcDNA3.1 (Invitrogen) as
described (27, 28). All constructs were verified by sequencing
and transient transfection into ST14A cells to observe expression using light microscopy (Zeiss AxioObserver.Z1).
Immortalized rat striatal neurons (ST14A cells) were grown
in 6-well plates and transiently transfected with Httex1p plasmids (1 g) with Lipofectamine 2000 (Invitrogen). ST14A cells
were grown in Dulbecco’s modified Eagle’s medium and 10%
fetal bovine serum at 33 °C (all reagents from Invitrogen). Each
plasmid was transfected in duplicate per experiment, and three
independent experiments were performed. At 24 and 48 h posttransfection, cells were lysed in radioimmune precipitation
assay buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA
(from a concentrated stock at pH 8.0), 1% Nonidet P-40, 0.5%
SDS) containing Complete Protease Inhibitor (Roche Diagnostics). A DC protein assay (Bio-Rad) was performed to determine protein concentration. Lysate (30 g) was added in a 1:1
ratio to loading buffer (150 mM Tris, pH 6.8, 33% glycerol, 1.2%
SDS) and loaded onto a 1% agarose gel containing 0.1% SDS and
run until the dye front had migrated at least 12 cm to allow for
maximum resolution of aggregates from the dye front. The proteins were then semidry-blotted (Owl HEP-1) onto a polyvinylidene difluoride membrane in transfer buffer (192 mM glycine, 2
5 mM Tris-base, 0.1% SDS, 15% MeOH). This blot was blocked
for 1 h in 5% bovine serum albumin in Tris-buffered saline
containing 0.1% Tween 20 at room temperature. The blot was
then probed with either EM48 (Millipore, 1:1000) or anti-GFP
antibody (Clontech, 1:1000). Peroxidase-conjugated AffiniPure
goat anti-mouse secondary (Jackson ImmunoResearch Laboratories) was used at 1:50,000 for 1 h at room temperature. Blots
were detected using PICO detection reagent (Pierce).
The same lysates used in the SDS-AGE assays were analyzed
by cellulose acetate filter-retardation assays. Lysate (30 g) was
diluted to 200 l with 2% SDS and filtered through cellulose
acetate membrane (Schleicher & Schuell, 0.2-m pore size)
with a Bio-Rad dot blot filtration unit. The assay was performed
as described (7). The blot was then probed with primary and
secondary antibodies and developed as described above.
SDS-AGE of R6/2 Mouse Brain Homogenates—At 4, 7, and 14
weeks of age R6/2 and wild type cortex were homogenized with
10 volumes of ice-cold sample buffer (100 mM Tris-HCl, pH 7.4,
150 mM NaCl, and a protease inhibitor mixture) by a ball-bearing homogenizer and sonification with 10 pulses/min and 15%
MAY 7, 2010 • VOLUME 285 • NUMBER 19

power. Samples were either analyzed without centrifugation
(total homogenates) or were centrifuged at 20,000 ⫻ g for 45
min at 4 °C and were then diluted 1:1 into non-reducing Laemmli sample buffer (150 mM Tris-HCl, pH 6.8, 33% glycerol,
1.2% SDS, and bromphenol blue). Bradford assays were used to
determine protein concentration in the homogenates before
the addition of Laemmli sample buffer. Total protein (50 g)
was loaded per SDS-AGE well. Mutant htt oligomers were
imaged after immunoreaction with EM48 antibody as
described above.
Electron Microscopic Analysis of Inclusions—Immunoelectron microscopy (EM) analysis of human HD cortex and
MCF-7 cells transiently transfected with FH969 –100Q were
performed as described (2, 29). Specifically, the cortex was dissected from a HD postmortem brain and fixed in 4% paraformaldehyde in phosphate-buffered saline overnight, immersed
in 20 –30% sucrose for 1 to 2 days, frozen on dry ice, and stored
at ⫺70 °C. The number of CAG repeats identified in the HD
allele was 69. Immunoperoxidase labeling was performed by
cutting frozen sections (40 m thick), incubated in 5% normal
goat serum (NGS), 1% bovine serum albumin, 0.2% Triton
X-100, and 1% H2O2 in phosphate-buffered saline, and then
incubated with a primary antibody specific to htt1–17 at a concentration of 1 g/ml in 5% NGS and 1% bovine serum albumin
for 40 h at 4 °C. Control experiments included omission of the
primary antibody and preadsorption with 50 g of N-terminal
peptide. Both of these controls resulted in the absence of staining. For analysis of ultrastructure, some immunoperoxidaselabeled sections were embedded in Epon, and thin sections
were cut on an ultramicrotome and mounted on Formvarcoated slot grids. MCF-7 cells were cultured onto poly-L-lysinecoated microslips and transfected with FH969 –100. Cells were
fixed in 4% paraformaldehyde in phosphate-buffered saline 3
days after transfection. Cells were incubated with antibody M5
and horseradish peroxidase-conjugated anti-mouse IgG antibody. The htt bodies were visualized with diaminobenzidine.
Cells were postfixed in 2.5% glutaraldehyde, incubated in 1%
osmium tetroxide and 1% uranyl acetate, dehydrated in increasing grades of alcohol, and embedded in an ethanol-soluble resin
(LX112, LADD). Embedded cells were sectioned (Ultracut E;
Reichert-Jung). Both cortex and MCF-7 cells were examined
with a JEOL 100CX electron microscope.

RESULTS
Formation of Spherical Oligomers in Vitro Depends on PolyQ
Length and Is Transient—In these experiments we used mutant
htt fragments with various polyQ repeat lengths (HD20Q,
HD35Q, HD46Q, and HD53Q) that were purified from Escherichia coli as a fusion to GST (Fig. 1A) (24). After purification
and centrifugation to remove small aggregates that might serve
as seeds, GST-HD fusion proteins appeared to be non-aggregated by AFM (data not shown). Cleavage of the GST moiety
with a site-specific protease (PreScission protease) released the
intact mutant htt fragments, initiating aggregation in a timedependent manner as reported (8, 15).
To determine the effects of polyQ length on the kinetics and
morphologies of aggregates formed by a mutant htt fragment,
preparations of soluble HD20Q, HD35Q, HD46Q, or HD53Q
JOURNAL OF BIOLOGICAL CHEMISTRY
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aggregate types at any given time for
mutant htt fragments. Oligomers
were detected at both concentrations of HD20Q but gradually dissipated (2 M) or remained relatively
stable (30 M) in number, depending on concentration. Importantly,
fibrils were not observed for
HD20Q at any time, unlike those
observed with longer polyQ lengths
(see below). For both concentrations of HD20Q, low amounts (⬍
0.3 aggregates/m2) of amorphous
aggregates were observed relative to
other aggregate types.
For HD35Q, a significant number
of large amorphous aggregates
(⬎1.0 aggregates/m2) and very few
(⬍0.1 fibrils/m2) short putative
fibrils formed at 2 M after 8 –24 h
of incubation (Figs. 2 and 3). Short
fibrillar species became the predominant aggregate type for
HD35Q incubated at 30 M after
8 h. The appearance of amorphous
aggregates of HD35Q at 2 M and
fibrils at 30 M was preceded by a
FIGURE 1. Experimental systems. A, a schematic representation is shown of the GST-htt exon 1 fusion peak population of oligomers,
proteins used in this study (HD20Q, HD35Q, HD46Q, or HD53Q). These fusion proteins contain a PreScission protease site located between GST and the htt fragment (not drawn to scale). Cleavage of the GST which quickly dissipated with time
initiates the aggregation reaction. B, schematics of the synthetic polyQ peptides used in this study are as the amorphous or fibrillar aggreshown. Flanking lysine residues were added to increase solubility. Representative AFM images and aggregate profiles that compare basic dimensions of oligomers (C), fibrils (D), and amorphous aggregates of gates increased in number. The
HD53Q (E) are shown. Height profiles under each image are indicated by colored lines. By using a combi- resultant distinct aggregate types of
nation of height and aspect ratio, relative populations of aggregates types can be distinguished and HD35Q (i.e. amorphous aggregates
quantified in a heterogeneous mixture.
versus fibrils) (supplemental Fig. 1)
that coincide with the dissipation of
were incubated at concentrations of 2 and 30 M and sampled oligomers under these conditions suggest competing, concenfor ex situ AFM analysis at 0, 1, 3, 5, 8, and 24 h after the addition tration-dependent aggregation pathways for mutant htt fragof protease (Fig. 2). To quantify the relationship between olig- ments. Furthermore, the amorphous aggregates have a granular
omers, fibrils, and amorphous aggregates, the number of each appearance, suggesting they may be composed of small oligaggregate type per m2 was measured as a function of time at omers that have accumulated together. This is consistent with
both concentrations (Fig. 3). Oligomers were defined as 2–10 the corresponding disappearance of the discrete oligomer popnm in height with an aspect ratio (longest distance across to ulation when these amorphous aggregates begin to appear.
For HD46Q, fibrils appeared after 3 and 1 h of incubation for
shortest distance across) less than 2.5, indicating a globular
structure. Fibrils were defined as aggregates greater than 4 nm 2 and 30 M, respectively. However, the HD46Q fibrils were
in height that had an aspect ratio greater than 2.5. Amorphous much longer and had a higher tendency to form bundles at 30
aggregates were defined as any aggregate greater than 10 nm in M than at 2 M incubations (Figs. 2 and 3). Similar to HD35Q,
height that did not have any obvious fibrillar morphology. the appearance of HD46Q fibrils was preceded by a peak popThese criteria were based on measured characteristics of rep- ulation in oligomers that dissipated with time coincident with
resentative examples of each respective aggregate type (Fig. 1, the accumulation of fibrils.
C–E). The number of fibrils in a bundle was estimated by countIncubations of HD53Q resulted in fibrils and fibril bundles at
ing the number of fibrils visible in the bundle.
both concentrations, with these structures appearing after 1
Oligomeric aggregates were observed for all htt fragments and 3 h, respectively, for 2 M incubations and 0 and 1 h, respecstudied, including HD20Q. As reported (7, 8), the appearance tively, for 30 M incubations (Figs. 2 and 3). Surprisingly, an
of fibrils was polyQ length and concentration-dependent, with increase in the oligomer population before the appearance of
fibrils appearing earlier, growing longer, and forming bundles fibrils was not observed for HD53Q under these experimental
with longer polyQ lengths and higher concentrations. Quanti- conditions. Rather, oligomer levels remained relatively stable
fication of distinct aggregate types per unit area (Fig. 3) dem- over time even though the number of fibrils steadily increased.
onstrated that aggregation results in a complex mixture of We hypothesized that the lack of a transient oligomer peak for
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to a single cysteine residue in vector-derived residues located between GST and htt (data not
shown). Analysis of 60 M HD53Q
in the absence of DTT resulted in
the formation of short fibrils only
after 3 h of incubation (supplemental Fig. 2A). Quantification of
the number of oligomers or fibrils
per m2 showed a gradual increase
in oligomers (supplemental Fig. 2B)
that peaked at 3 h, coinciding with
the appearance of fibrils (supplemental Fig. 2C). After 3 h, the
oligomer population steadily decreased, whereas the number of
fibrils remained relatively constant.
In agreement with the results with
HD35Q and HD46Q, formation of
HD53Q oligomers preceded fibril
formation. Moreover, as fibrils
appeared, oligomers gradually dissipated, indicating that oligomers
were destabilized in the presence of
fibrils, incorporated into fibrils, or
were direct precursors of fibrils.
These results indicate that, although a mutant htt fragment with
a non-pathological polyQ length
(20Q) forms oligomers, these oligomers do not structurally transition
to fibrils, as observed with mutant
htt fragments that contain polyQ
repeats in the pathological range
(⬎35Q). These results suggest that
these oligomers may have a different structure than those formed
with disease-causing polyQ repeat
lengths.
FIGURE 2. Oligomers and fibrils formed by a mutant htt fragment depend on polyQ length and concenOligomers Formed by a Mutant
tration. AFM images demonstrate the aggregation of mutant htt fragments with polyQ repeats of 20Q, 35Q,
46Q, or 53Q. Incubations with protein concentrations of 2 M (A) and 30 M (B) were imaged at different time htt Fragment Are Highly Heterogepoints after the addition of protease. Examples of oligomers, fibrils, fibril clusters, and large amorphous aggre- neous
in Size and Subunit
gates are indicated by yellow, red, green, and blue arrows, respectively. Although oligomers were observed for
Composition—We
next quantified
HD20Q, fibrillar aggregates were not. For mutant htt fragments with longer polyQ repeats, heterogeneous
mixtures of aggregate types appeared at later times. The appearance of fibrillar aggregates of HD35Q was height and volume distributions for
concentration-dependent. At 2 M, HD35Q began to form large amorphous aggregates but at 30 M HD35Q
formed a large number of short fibrils. At late times, fibrils and fibril bundles were the dominant morphology oligomers formed by each mutant
htt construct (2 M) as a function of
for HD46Q and HD53Q, with fibrils appearing earlier for HD53Q at both concentrations.
time (supplemental Fig. 3). Volume
HD53Q resulted from the rapid kinetics of fibril formation in measurements were partially corrected for the contribution
this experiment and that the peak oligomer population may due to the finite size of the probe (26). Although the size distrihave already occurred by the time the reaction buffer was sam- butions for HD20Q oligomers were relatively constant during
aggregation (mode of height ⬃2– 4 nm and volume ⬃400 –750
pled by AFM.
To test this hypothesis, we changed conditions of the aggre- nm3, respectively), distributions for oligomers, formed by
gation reactions. Our previous experiments were all performed mutant htt fragments with ⬎35Q, became larger and more hetwith the reducing agent DTT in the reaction buffer. However, erogeneous with increasing time (mode of height ⬃6 –9 nm and
in independent experiments we serendipitously found that the volume ⬃900 –1200 nm3). Using an independent analysis, we
kinetics of fibril formation by mutant htt fragments was much used the corrected volume distributions of oligomers to estislower when DTT was omitted from the reaction buffer, appar- mate the number of protein molecules per oligomer for
ently by reducing the efficiency of cleavage of GST from htt due HD20Q, HD35Q, HD46Q, or HD53Q, respectively (Fig. 4) (for
MAY 7, 2010 • VOLUME 285 • NUMBER 19
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FIGURE 3. Aggregate species of mutant htt fragments change temporally
in a polyQ length- and concentration-dependent manner. Quantification
of aggregate types observed in AFM images for incubations HD20Q, HD35Q,
HD46Q, and HD53Q at 2 M and 30 M. The numbers of oligomers (A), fibrils
(B), and amorphous (C) aggregates per m2 were calculated for all images in
Fig. 2. The appearance of fibrils occurred earlier for longer polyQ repeat
lengths. Although HD20Q formed oligomers at both concentrations, fibrils
were not observed. For HD35Q, a peak population of oligomers preceded the
formation of amorphous aggregates (2 M) or fibrils (30 M). A peak population of oligomers also preceded the appearance of fibrils of HD46Q at both
concentrations. As fibrils of HD53Q appeared early in the experiment, a peak
oligomer population preceding the appearance of fibrils was only observed if
the kinetics of aggregation reactions were decreased (see supplemental Fig. 2).

details on this analysis see supplemental Experimental
Procedures). Collectively, these analyses indicate that oligomeric species with a broad size range are observed only with
longer polyQ repeats and that oligomers formed in vitro are
highly heterogeneous and change in subunit composition over
time.
Mutant htt Fragments with Expanded PolyQ Repeats Form
Discrete Annular Aggregates—Although oligomeric and fibrillar structures account for the vast majority of aggregates in the
incubation studies, other discrete annular structures were also
occasionally observed (supplemental Fig. 4). These structures
were exceedingly rare, were not observed in all incubations, and
only appeared in incubations of HD46Q and HD53Q. Large
annular structures (supplemental Fig. 4, A and B) with inner
diameters of ⬃30 –130 nm were the most common. For
HD46Q and HD53Q, they appeared at ⬃1 per 500 m2 when
imaged by AFM. By contrast, spherical oligomers appeared at a
rate of 10,000 per 500 m2. Smaller annular aggregates
(supplemental Fig. 4, C and D) observed for HD46Q and
HD53Q with inner diameters of ⬃10 nm were detected even
more rarely. Each of their five globular subunits was comparable in size and morphology to spherical oligomeric aggregates,
suggesting that some oligomers might be able to organize into
these structures. Because of the limited number of observations
of both annular structures, however, it was impossible to systematically quantify the effects of polyQ length on their formation, except that they were never observed for HD20Q or
HD35Q.
Tracking the Fate of HD53Q Aggregates in Solution—To
directly observe the fate of individual aggregates formed by a
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FIGURE 4. Oligomers formed by mutant htt fragments are highly heterogeneous in size. Based on corrected volume measurements (see
supplemental Fig. 3) and the molecular mass of each htt exon 1 fragment,
the numbers of molecules per oligomer observed for 2 M incubations of
HD20Q, HD35Q, HD46Q, or HD53Q were calculated for each time point of
aggregation from Fig. 2. The plots are color-coded such that darker colors
represent a greater abundance of oligomers composed of that number of
molecules. Black arrows indicate where ⬃400 kDa oligomers would be
observed, and the maximum size in kDa is represented in the plots as
marked. Based on this analysis, htt exon 1 fragments form a mixture of
oligomers ⬃400 kDa and larger, similar to what was observed by SDS-AGE
in vitro and in vivo (see Fig. 7).

mutant htt fragment in solution, in situ AFM experiments were
performed with HD53Q (Fig. 5). Fresh monomeric preparations of purified HD53Q were injected directly into the fluid cell
of the AFM at a final concentration of 2 M and imaged continuously (Fig. 5A). Within 9 min after injection, a diffuse film of
soluble protein and several distinct oligomers (Fig. 5A, yellow
arrows) appeared on the surface, entirely covering the mica
surface. The number of oligomers gradually increased over
time as more oligomers formed in solution and were deposited
onto the surface (Fig. 5B). The oligomeric structures did not
exhibit lateral mobility, as commonly observed for other amyloid forming peptides, such as A␤ (30, 31), perhaps due to their
affinity for the protein film on the surface. The vast majority of
oligomers were stable, neither desorbing from the surface nor
seeding the appearance of fibrillar aggregates during the time
course of the experiment. On rare occasions, oligomers
appeared to seed the formation of a small fibril (Fig. 5A, red
arrows). However, most fibrils appeared in the absence of oligVOLUME 285 • NUMBER 19 • MAY 7, 2010
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tracking the change in surface area
of individual fibrils that gradually
increased due to this elongation
(Fig. 5E). However, ⬃80 –120 min
after the addition of HD53Q monomer, branching appeared along the
fibrils both at the ends where elongation first appeared and from their
periphery, resulting in an accelerated increase in fibril area (indicated
by the black arrow in Fig. 5E). The
fibrils then appeared to accumulate
soluble HD53Q around their entire
periphery both as fibrillar branches
and some amorphous clumping,
suggesting that large amorphous
aggregates may have underlying
fibrillar structure (supplemental
Movie 1). In the presence of fibrils,
the formation of oligomeric species
was suppressed (Fig. 5, compare D
and B), indicating that there
was competition between soluble
HD53Q-forming oligomers and
incorporation into and/or accumulation around the preformed fibrils.
Synthetic PolyQ Peptides Form
Oligomers
and Fibrils in Solution with
FIGURE 5. A mutant htt fragment forms oligomers in solution. A, monomeric preparations of HD53Q were
imaged in solution on mica at a concentration of 2 M. The yellow arrows indicate oligomers that are stable Faster Kinetics Than Observed with
throughout the experiment. The red arrows indicate an oligomer that coalesced into a fibril. The blue and black
Mutant htt Exon 1—In studies by
arrows indicate fibrils that appeared without a clear oligomeric precursor. B, the number of oligomers and
fibrils per unit area was determined as a function of time. Oligomers appeared on the surface by 9 min with a Wetzel and co-workers (9, 25,
steady increase in abundance over time. The vast majority of these oligomers did not further aggregate into 32–35), synthetic polyQ peptides
fibrillar structures. Very short (⬍200 nm in length) fibrillar structures also appeared within 9 min. Although the
number of fibrils did increase slightly, they were far less abundant than oligomers. C, HD53Q was aggregated aggregate into fibrils in a polyQ
to a fibrillar state, deposited on mica, and imaged in solution. Next, a monomeric preparation of HD53Q (2 M) length-dependent manner. Unlike
was injected into the fluid cell. D, the number of oligomers per unit area was determined as a function of time, htt exon 1, even non-pathological
illustrating that fewer oligomers formed in the presence of fibrils. E, the surface area occupied by individual
fibrils was monitored as a function of time. Initially, fibrils appeared to elongate predominately at the fibril polyQ lengths readily formed fibrils.
ends, resulting in a slight increase in occupied surface area. However, ⬃88 min (marked by black arrowhead) Surprisingly, oligomeric structures
after the addition of HD53Q monomer, branching appeared on several fibrils, increasing the rate of change in
occupied surface area. The fibrils then appeared to accumulate soluble HD53Q as the fibrils expanded in all were apparently never observed in
these studies. More recently, they
directions (also see supplemental Movie 1).
added sequences that normally
omeric precursors (Fig. 5A, blue arrows). These fibrils may have flank the polyQ domain in htt exon 1 to synthetic polyQ pepformed from oligomers in solution before depositing onto the tides (36) to partially mimic the htt exon 1. They stated that
mica surface. The fibrils observed were quite short (⬍200 nm) these flanking sequences imparted a novel aggregation pathway
on the polyQ peptide in which it formed oligomers similar to
and much less abundant than oligomers (Fig. 5B).
We next performed an order of addition experiment in which htt exon 1 and that these sequences were in fact necessary for
purified HD53Q monomers were added to preformed HD53Q oligomer formation (i.e. that synthetic polyQ peptides alone
fibrils previously immobilized on the mica surface (Fig. 5C and could not form oligomers under any conditions).
We examined the effects of polyQ length on the real-time
supplemental Movie 1). Control experiments demonstrated
that conditions for these experiments did not appear to alter or aggregation of synthetic peptides by in situ AFM to determine
damage pre-existing fibril morphology for up to 6 h of direct what structures these simple peptides could form and to comimaging (not shown). HD53Q was incubated at 37 °C until pare these results directly with those we obtained using authenfibrils were formed. These fibrils were deposited on mica and tic htt exon 1. Freshly prepared solutions of completely solubiwashed with buffer to remove any residual HD53Q monomer lized synthetic peptides of K-Q7-K, KK-Q23-KK, and
and/or aggregates remaining in solution. Next, a freshly puri- KK-Q32-KK were injected directly into the AFM fluid cell to a
fied 2 M HD53Q monomeric preparation, which had been final concentration of 20 M and imaged continuously on mica
incubated with protease on ice for 1 h, was added to the fluid (supplemental Fig. 5A). A few oligomers of K-Q7-K appeared
cell. Initially, elongation of individual preformed fibrils initially and steadily increased in abundance (supplemental
occurred gradually from both fibril ends. This is indicated by Fig. 5B). Short, metastable fibrils appeared as early as 25–50
MAY 7, 2010 • VOLUME 285 • NUMBER 19
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min after the addition of K-Q7-K. These early fibrils would
often quickly disappear; however, stable fibrils eventually
formed (beyond 150 min). Despite this dynamic fibril stability,
the total number of fibrils detected at any given time increased
steadily but at a slower rate than oligomers (supplemental
Fig. 5B). For K-Q7-K, oligomers remained the dominant aggregate morphology. KK-Q23-KK initially aggregated into a large
number of oligomers (supplemental Fig. 5, A and B), with a
small population of short but stable fibrils appearing within 17
min. This fibril population steadily increased. By 44 min, large
bundles of KK-Q23-KK fibrils appeared that continued to accumulate and grow in size, often branching in many directions.
Fibrils eventually became the dominant morphology of
KK-Q23-KK aggregates, with oligomers reaching a peak population at 71 min before gradually beginning to dissipate. When
freshly solubilized preparations of the KK-Q32-KK peptide
were imaged in solution (supplemental Fig. 5A and Movie 2),
small oligomeric and short putative fibrillar structures
appeared on the surface within a few min (supplemental Fig. 5B). For higher resolution AFM images of KK-Q32-KK
oligomers and putative fibrils, see supplemental Fig. 6. With
time, more aggregates of various types (i.e. oligomers, fibrils,
and fibril bundles) appeared on the surface; however, fibrillar
structures dominated the aggregate morphology by 35 min. For
KK-Q32-KK, oligomers quickly reached a peak population
before dissipating, with a much sharper transition than
KK-Q23-KK (supplemental Fig. 5B), reminiscent of studies
with a mutant htt fragment with longer polyQ lengths (Fig. 3).
Once fibrils were established on the surface, most of the new
peptide appearing on the surface was associated with these
fibrillar structures (supplemental Fig. 5C), which was also similar to the observations for HD53Q monomer addition to preformed fibrils described above (Fig. 5, C–E). The total amount
of aggregation was quantified for each peptide as the percent
surface area occupied by aggregates as a function of time
(supplemental Fig. 5C). Based on this analysis, the rate of total
aggregation correlated with polyQ length. For KK-Q23-KK and
KK-Q32-KK, an initial lag phase preceded acceleration in
aggregation, and the acceleration was more pronounced for
KK-Q32-KK.
We observed two apparent mechanisms for the disappearance of oligomers; oligomers appeared to be nucleation sites for
fibril growth or were incorporated into adjacent fibrillar structures. However, the relative stability of individual oligomers
varied greatly. We tracked the fate of 66 oligomers of
KK-Q32-KK that first appeared at 26 min (20 M peptide concentration) to determine how long each remained in the oligomeric state (supplemental Fig. 5D). Half of the oligomers had
nucleated fibril growth within 18 min and 71% within 50 min.
However, nine oligomers were stable for longer than 150 min,
with three lasting more than 200 min. Varied oligomer stability
and dissipation mechanisms are further illustrated by timelapse sequences of AFM images (supplemental Fig. 7).
Although most oligomers nucleated fibril growth within minutes of appearing (supplemental Fig. 7, red arrows), other oligomers remained stable for extended periods (⬎200 min)
(supplemental Fig. 7, black arrows). Some apparently stable
oligomers were eventually assimilated by adjacent fibrillar
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structures that grew directly onto the stable oligomers (supplemental Fig. 7, blue arrow), incorporating them into their structure. The varied stability of individual oligomers suggests that
these structures have to overcome an energy barrier to a structural rearrangement to initiate fibril growth, allowing some
oligomers to remain relatively stable for extended times. These
results are also consistent with the observed heterogeneity in
the oligomer size for mutant htt fragments (Fig. 4), which may
underlie their relative differences in stability.
We also tracked elongation and growth once individual
fibrils appeared in the KK-Q32-KK experiment (supplemental
Fig. 8). Although some fibrils arose from clear oligomeric precursors, most initially appeared as intact fibrils (supplemental
Fig. 8, A and B). Fibrils grew in various directions, and individual fibril structures often exhibited different growth patterns
and morphologies at different times. Elongation often occurred
from fibril ends, but extensive branching, resulting in elongation in multiple directions, was common (supplemental
Fig. 8C). Often a single elongated fibril would exhibit variable
height/width along its contour. With time, the shorter/thinner
regions of fibrils transitioned to resemble the taller/thicker
regions. Fibrils grew together, forming a large network of intertwining fibers.
In situ AFM experiments with KK-Q32-KK were also carried
out at a concentration of 5 M and directly compared with the
aggregation of HD53Q at the same concentration (Fig. 6A). At
this concentration, the number of KK-Q32-KK oligomers and
fibrils initially increased at similar rates (Fig. 6B), but as the
number of fibrils continued to increase, oligomers again dissipated. The transition was not as sharp as in the 20 M experiment and occurred at a later time (⬃80 min). This was in stark
contrast with HD53Q aggregation in which oligomer formation
dominated the entire duration of the experiment with only a
few putative fibrils forming (Fig. 6, A and B). Large amorphous
aggregates of KK-Q32-KK appeared that were not seen at
higher concentrations. Nevertheless, fibrils were still the
dominant morphology observed. The excess solution of
KK-Q32-KK (i.e. that was not injected into the fluid cell) was
sampled after 5 h of preparation and imaged ex situ (Fig. 6C).
Interestingly, the observed mixture of aggregate morphologies
consisted of oligomers and two distinct types of fibrils: shorter
(⬃1–2 nm tall, red arrows) and taller (⬃5–7 nm tall, blue
arrows) fibrils. This was in contrast to experiments with the
mutant htt fragment in which only a single type of fibril morphology was observed (Fig. 2). Thus, our studies show synthetic
polyQ peptides can clearly form on oligomeric structures even
in the absence of flanking htt exon 1-like sequences albeit with
much faster kinetics than htt exon 1 that may have eluded their
previous identification. However, no annular morphologies
were ever observed in experiments with synthetic polyQ
peptides.
A Mutant htt Fragment Forms Oligomers in a PolyQ Lengthdependent Manner in Neurons and Brains—Although our analyses indicate mutant htt fragments form oligomers in a polyQ
length-dependent manner under cell free conditions, we
wanted to determine whether they exhibited similar properties
in cultured neurons, brains from a transgenic mouse model of
HD, and HD patient brains. Oligomers, however, in the absence
VOLUME 285 • NUMBER 19 • MAY 7, 2010
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FIGURE 6. The synthetic polyQ peptide KK-Q32-KK forms oligomers with
faster kinetics than a mutant htt fragment. A, in situ AFM experiments were
performed with 5 M HD53Q and KK-Q32-KK. B, the number of oligomeric and
fibrillar aggregates formed by HD53Q and KK-Q32-KK was measured as a
function of time. For KK-Q32-KK, the number of oligomers peaked (⬃80 min)
before dissipating, as the number of fibrils continued to increase. Large amorphous aggregates of KK-Q32-KK also appeared. Under these conditions,
HD53Q only formed oligomers, which steadily increased in number as a function of time. C, ex situ AFM image of KK-Q32-KK sampled 5 h after incubation
at 5 M demonstrating that the peptide formed a mixture of aggregates consisting of oligomers (yellow arrows) and two distinct types of fibrils: narrower
fibrils (⬃1–2 nm tall, red arrows) and taller fibrils (⬃5–7 nm tall, blue arrows).

of purification procedures that could potentially introduce artifacts cannot be readily identified in cell or brain homogenates
by AFM due to the high background of other cellular contaminants. Therefore, we used SDS-AGE with Western analysis to
directly compare oligomers formed by a mutant htt fragment
under cell-free conditions to those in total homogenates from
neurons and brains. Although this technique was used recently
to resolve oligomers formed by mutant htt fragments from
yeast (37) and mammalian systems (19), it has not been used
under cell-free conditions nor to systematically analyze the
effects of polyQ length dependence on oligomer formation.
We first incubated purified GST-HD20Q and GST-HD53Q
in the absence and presence of protease at 12.5 M for 72 h.
SDS-AGE with Western analysis probed with an antibody
raised to the N terminus of htt (EM48) (38) indicated that, only
in the presence of protease, HD53Q, but not HD20Q, formed
oligomeric species that fractionated as a smear above 400 kDa
(Fig. 7A), similar in size to those described in cultured cells and
brains from HD mouse models (19). The apparent molecular
masses of these oligomers ranged from ⬃400 kDa to several
mDa (supplemental Fig. 9). HD53Q oligomers initially
increased up to 8 h and were relatively stable from 8 – 48 h but
decreased in abundance at 72 h of incubation.
We next used SDS-AGE with Western analysis to analyze
total homogenates from an immortalized cell line (ST14a)
MAY 7, 2010 • VOLUME 285 • NUMBER 19

derived from rat striatal neurons transiently transfected with
plasmids that express GFP alone or mutant htt exon 1 with 25Q,
46Q, or 97Q fused at the C terminus to GFP. Homogenates
from cells that expressed HD46Q-GFP and HD97Q-GFP, but
not GFP or HD25Q-GFP, formed oligomers that migrated as
smears at an apparent molecular mass above 400 kDa (Fig. 7, B
and C), similar to those formed by HD53Q in vitro, although the
apparent size distribution was broader in cell homogenates
(supplemental Fig. 9). Interestingly, oligomers from cell homogenates that expressed HD97Q-GFP showed a smaller and less
heterogeneous apparent size distribution than from HD46QGFP homogenates. As HD97Q-GFP-expressing cells form significantly more inclusion bodies than HD46Q-GFP cells (data
not shown), we hypothesize that the narrower size distribution
observed in HD97Q-GFP-expressing cells is due to a greater
propensity for mutant htt exon 1 with this polyQ repeat
length to form fibrils, as observed in our in vitro studies.
However, oligomers formed by HD46Q-GFP and HD97QGFP continued to accumulate with incubation time (Fig. 7, B
and C). A similar result was observed in a filter retardation
assay that detects all SDS-insoluble aggregated material
greater or equal to the pore size (0.2 m) of the membrane
(Fig. 7D).
We next performed SDS-AGE and Western analysis using
total brain homogenates from R6/2 mice, a transgenic mouse
model of HD that expresses mutant htt exon 1 (16, 39), and
non-transgenic littermate controls. We analyzed homogenates
from three independent transgenic lines of R6/2 mice that
expressed mutant htt exon 1 with 110Q, 160Q, or 220Q repeats.
As observed in vitro and in ST14a cells, mutant htt exon 1
formed oligomers in R6/2 mouse brains that migrated above
400 kDa as detected by the EM48 antibody (Fig. 7E). Homogenates from 220Q mice had the narrowest apparent size distribution and a significantly lower level of antibody staining (Fig.
7, E and F, and supplemental Fig. 9) when compared with R6/2
mice with 110Q or 160Q despite the rapid and widespread distribution of inclusion bodies in these mice (40). As described
(19), oligomers in R6/2 brain homogenates appeared to
increase in a time-dependent manner (Fig. 7, G and H). Because
the oligomeric species we detected in SDS-AGE could also be
derived in part from fibrillar species, we performed SDS-AGE
with Western analysis with the supernatant fractions of brain
homogenates after centrifugation at 20,000 ⫻ g, which sediments all fibrillar material (15). SDS-AGE of these samples indicated mutant htt exon 1 forms soluble, non-sedimentable oligomers in a time-dependent manner (Fig. 7I). Similar results
were obtained after centrifugation of recombinant HD53Q
(data not shown). Finally, a direct comparison of recombinant
HD53Q oligomers with those from neurons and R6/2 brain
homogenates demonstrated that oligomers fractionate in SDSAGE to similar apparent molecular masses ranging from 400
kDa to several mDa in size (supplemental Fig. 9).
We next used EM to examine the size and morphology of
mutant htt inclusions formed in cortical neurons from a postmortem HD brain (69Q in the HD allele) (Fig. 8, A and B) and in
MCF7 cells (a human breast adenocarcinoma cell line) transfected with a mutant htt fragment containing 100Q (Fig. 8, C
and D). After immunoperoxidase labeling with a primary antiJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 7. A mutant htt fragment forms oligomers in a polyQ length-dependent manner in neurons and brains. A, SDS-AGE with Western analysis
indicates that a mutant htt fragment (HD53Q) forms oligomers that migrate as a smear above ⬃400 kDa when detected with an anti-htt antibody (EM48). B and
C, a mutant htt fragment forms oligomers in a polyQ length-dependent manner in ST14A cells similar in apparent size to those formed under cell-free
conditions. Note that oligomers formed by HD97Q-GFP are less heterogeneous in size than those formed with shorter polyQ lengths but that the intensity of
oligomers as detected by antibody reactivity increases as a function of time in ST14A cells. D, a filter-trap retardation assay shows that the total amount of
SDS-insoluble aggregates increases as a function of polyQ length and time in ST14A cells that express a mutant htt fragment. E and F, a mutant htt fragment
forms oligomers in total brain homogenates from R6/2 mice that are similar in apparent size to those formed under cell-free conditions. Note that oligomers
formed by a mutant htt fragment with 220Q are less heterogeneous in size than those formed with shorter polyQ lengths and that the intensity of antibody
reactivity also is significantly decreased in R6/2 mice with 220Q. WT, wild type. G and H, SDS-AGE with Western analysis on total brain homogenates show that
a mutant htt fragment forms oligomers that significantly increase as a function of time in R6/2 mice with 110Q. I, SDS-AGE with Western analysis on the
supernatant fraction of a total brain homogenate after centrifugation shows that a mutant htt fragment forms soluble oligomers that increase as a function of
time in R6/2 mice with 110Q. *, p ⬍ 0.05; ***, p ⬍ 0.0001 (one-way analysis of variance).

body to htt1–17 (2), mutant htt inclusions occupying large
areas within nuclei of cortical neurons from the HD brain were
readily observed (Fig. 8A, black arrow). Such structures were
never observed in control, age-matched brains (data not
shown). At higher resolution (Fig. 8B), these inclusions
appeared to be comprised of a heterogeneous mixture of aggregates consisting of granular/oligomeric (arrowheads) and fibrillar (arrows) morphologies, with similar dimensions to oligomers and fibrils observed by AFM with mutant htt exon 1
under cell-free conditions (Fig. 1). In a MCF7 cell transfected
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with Flag-htt1–969-100Q and incubated with antibody M5, a
large cytoplasmic htt inclusion appeared adjacent to the
nucleus (Fig. 8C). This htt inclusion was composed of a core of
unlabeled fibrils (Fig. 8D, arrows) surrounded by a periphery of
immunoreactive granular/oligomeric species (Fig. 8D, arrowheads). Importantly, the granular/oligomeric structures observed by EM in both cortical neurons and transfected MCF7
cells were similar in lateral dimension to the oligomers
observed by AFM. Many of the granular/oligomeric structures
observed by EM in both the cortical neurons (Fig. 8B, ringed
VOLUME 285 • NUMBER 19 • MAY 7, 2010
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FIGURE 9. A model for the misfolding and aggregation of a mutant htt
fragment. A native monomer can continuously misfold to sample distinct
monomeric conformers. The relative number and stability of these conformers may be polyQ length-dependent. Some of these misfolded monomers
potentially can lead to off-pathway aggregates, such as large annular aggregates. Others can form globular oligomeric aggregates. The size and stability
of oligomeric aggregates can vary widely and are also polyQ length-dependent. These oligomers can further self-assemble or accumulate into other
aggregate morphologies, such as small annular aggregates composed of
oligomeric subunits, large amorphous aggregates, and fibrils. In this model a
major structural transition must occur within an oligomer to initiate fibril
elongation. Once this transition occurs, oligomers and monomers can
directly accumulate on the fibril, causing fibril elongation. Many of these
higher order aggregates can accumulate together to form large aggregates
that make up inclusions.

FIGURE 8. Mutant htt forms oligomers in HD brains. Mutant htt was
detected with EM using the immunoperoxidase method and a primary antibody to htt1–17. Analysis was performed with a transmission electron microscope (JEOL 100CX). The peroxidase reaction product appears as electron
dense label. A and B, electron micrographs are from a cortical neuron in
human postmortem HD brain. The CAG repeats were 17 and 69. Note that the
labeled inclusion occupies a large area at the center of the nucleus (nuc). The
composition of the inclusion is highly heterogeneous consisting of granular/
oligomeric and fibrillar structures. Stacks of labeled fibrils are present at the
upper part of the inclusion and along the right at the open arrow, which is magnified in B. In B, note the presence of small, labeled granular/oligomeric structures of different sizes (arrowheads) that are similar in lateral dimensions to
those observed by AFM analysis of mutant htt fragments in vitro. Fibrils
(arrows) and structures that resemble beads on a string (ringed arrow) are also
indicated. C and D, electron micrographs of an MCF7 cell transfected with
Flag-htt1–969-100Q. In C, a large cytoplasmic inclusion appears adjacent to
the nucleus (nuc) at the open arrow. A portion of the inclusion is shown at
higher magnification in D. The inclusion consists of a core of unlabeled fibrils
(arrows) and a periphery of immunoreactive granular/oligomeric structures
(arrowheads). Some of the granules/oligomers form linear arrays (“beads on a
string”) similar to that observed in the human HD brain (B, ringed arrow). Scale
bars on left panels ⫽ 1 m and on right panels ⫽ 100 nm.

arrow) and in MCF7 cells (Fig. 8D, arrowheads) appeared to be
laterally associated, similar to beads on a string.

DISCUSSION
In this study we present several findings. First, we provide
direct evidence that a mutant htt fragment and synthetic polyQ
peptides readily form spherical oligomers. Second, we show
that oligomer formation precedes fibril formation, that oligomers quickly disappear as fibrils form, and that this transition
appears to be polyQ length- and concentration-dependent.
Third, we show that mutant htt fragments with expanded
polyQ domains, but not synthetic polyQ peptides, can form a
MAY 7, 2010 • VOLUME 285 • NUMBER 19

variety of discrete annular structures. Fourth, we show that on
rare occasions spherical oligomers can be direct precursors of
fibrils; however, the individual fate, stability, and size of oligomers vary widely, suggesting different underlying structures of
these aggregates. Fifth, we show a mutant htt fragment forms
oligomers in a polyQ length-dependent manner in an immortalized striatal cell line and in brain homogenates from a mouse
model of HD that are similar in apparent size to those formed in
vitro. Finally, we show by immunoelectron microscopy that oligomeric-like structures are readily detected in HD brains. Collectively, these results underscore the complex nature of polyQ
aggregation and the importance of polyQ length and amino
acid context on the kinetics and morphologies of mutant htt
aggregation. As the length of the polyQ expansion in htt is
tightly correlated with disease onset and severity in HD, the
results we present are consistent with the hypothesis that oligomers or subsets of oligomers may play a causative role in HD
pathogenesis.
Based on these and previous studies, we propose a model of
mutant htt aggregation (Fig. 9). In this model, aggregation initiates from monomers that are continuously sampling multiple,
distinct conformations. By analogy to a freely jointed
homopolymeric chain, one can speculate that the relative number and stability of these conformers would depend on polyQ
length and that a subset of these conformers might seed higher
order aggregation pathways. Although our previous studies
with monoclonal antibodies strongly implicate multiple monomeric polyQ conformations in a mutant htt fragment (22), Kim
et al. (41) recently provided direct structural evidence of this at
near-atomic resolution. These results suggest that, at least in
principle, different monomeric conformations might lead to
oligomers that also possess different structures, perhaps mediated by different hydrogen-bonded networks between polyQ
JOURNAL OF BIOLOGICAL CHEMISTRY
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residues (42). Fibril formation appears to proceed via two distinct pathways; 1) direct nucleation from a monomer or small
multimer and 2) one with a higher order, spherical, oligomeric
intermediate. Although it is difficult to determine whether
either pathway is dominant, these pathways do not appear to
be mutually exclusive, and at least at high protein concentrations, monomer addition to preformed fibrils appears to
predominate.
Our AFM and biochemical analyses indicate that oligomers
are highly heterogeneous in size. The stability of oligomeric
aggregates is also highly variable, and the transition from oligomeric to fibrillar aggregates occurs with faster kinetics at longer
polyQ lengths. Interestingly, it appears that a thermodynamically driven structural transition is necessary for an oligomer to
nucleate fibril formation. Our data also suggest oligomers form
and may be direct components of other higher order assemblies, such as annular structures and large amorphous aggregates. Once formed, fibrils often appear to branch while simultaneously accumulating monomer, oligomers, and amorphous
structures. Overall, our results demonstrate clearly that a heterogeneous mixture of aggregate morphologies can co-exist in
a dynamic equilibrium at any given time during an aggregation
reaction. We speculate that the propensity for the polyQ
domain to adopt multiple conformations in monomeric and
higher order structures may in fact underlie mutant htt toxicity,
as the number of toxic, gain-of-function interactions that
mutant htt participates in may be proportional to the number
of toxic conformers that it samples. However, it is also conceivable that perhaps only some subsets of these structures are most
chemically reactive.
Our results provide further evidence to support the hypothesis that flanking amino acids modulate the conformation and
aggregation of polyQ tracts and likely their biological activities.
The polyQ repeat in mutant htt exon 1 is flanked by an N-terminal 17-amino acid ␣-helix and a C-terminal polyproline helix
(41). These ordered flanking sequences might exert influence
over the polyQ tract, perhaps restraining its ability to adopt
multiple conformers (43) and by strongly inhibiting aggregation (32, 36, 43). The addition of oligoprolines to polyQ peptides decreases the rate of formation and stability of amyloid
aggregates (32). The importance of amino acid context on
polyQ aggregation has been shown in several studies and systems (44 – 48). Sequences that flank the polyQ repeat in mutant
htt fragments also modulate toxicity in yeast models in cis and
trans during aggregation (49, 50). In this study the most striking
difference between synthetic polyQ peptides and a mutant htt
fragment was the length of the polyQ tract necessary to form
fibrils. Although synthetic peptides with even 7Q readily
formed fibrils, only polyQ lengths in the disease-causing range
(ⱖ35Q) did so in a mutant htt fragment.
Although previous studies suggested synthetic polyQ peptides do not form oligomers and aggregate slower than peptides
designed to partially mimic htt exon 1 (9, 33, 34, 36), our in situ
AFM experiments where we directly compared these peptides
with bona fide mutant htt exon 1 under identical experimental
conditions provide unequivocal evidence that polyQ peptides
indeed form oligomers albeit with much faster kinetics than htt
exon 1. We believe this faster kinetics may be partly explained
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by the influence of amino acid context. Although experiments
by Wetzel and co-workers (36) used “htt exon 1-like” polyQ
peptides that lack the ⬃40 amino acids C-terminal to the
polyproline repeat in htt exon 1, our studies were performed
with full-length, purified mutant htt exon 1. More importantly,
our in situ AFM experiments allowed us to sample synthetic
polyQ peptides continuously within minutes of initiating
aggregation, whereas previous studies that used transmission
electron microscopy were sampled only at later time points of
aggregation when fibrils predominate (36). Differences
between our results and those described previously might also
be explained by differences in buffer conditions, as all of our
studies were performed using a Tris-based buffer, whereas
those by Wetzel and co-workers (36) were performed in phosphate-buffered saline. Although the precise fragments of
mutant htt that accumulate in HD is unknown, fragments
slightly larger than exon 1 have been detected, providing a
strong rationale for the use of exon 1 as a model system to study
htt aggregation (10, 51). However, it will also be interesting to
determine whether longer mutant htt fragments and intact
mutant htt itself exhibit a similar polyQ length dependence of
oligomer formation.
Here, we used SDS-AGE with Western analysis to directly
compare the effects of polyQ length on mutant htt oligomerization with purified proteins to that in an immortalized cell line
derived from striatal neurons and in the brains of a mouse
model for HD. We observed several important similarities and
differences between the behavior of mutant htt fragments in
vitro and in vivo. Although purified mutant htt fragments form
oligomeric species in the same apparent size range to that
observed in cell and brain homogenates, the latter appear to be
even more heterogeneous in size. In contrast to that observed in
vitro, where mutant htt oligomers are transient structures that
dissipate coincident with fibril accumulation (at least at higher
protein concentrations), oligomers formed in cell and brain
homogenates accumulate as a function of time. One parsimonious interpretation of these results is that oligomers persist in
vivo due to the constant supply of newly synthesized monomeric mutant htt that leads to steady-state equilibrium, in contrast to in vitro aggregation reactions, when monomeric mutant
htt is limiting and a chemical equilibrium exists. This is not to
say that fibrils do not form in vivo, as these structures have been
described in a mouse model of HD (16, 39) and in HD brains (2)
as well as in this study (Fig. 8). It is noteworthy that at lower
protein concentrations in vitro, oligomers appear to predominate. Although we and others (2, 52–54) showed that oligomers
exist in vivo, we hypothesize that the high local concentration of
mutant htt fragments in an inclusion body in neurons is likely
sufficient for fibril formation to predominate. This model
would be consistent with cellular studies that suggest inclusion
body formation is a conserved, microtubule-dependent
homeostatic mechanism to detoxify mutant htt, where increasing the local concentration of mutant htt would presumably
lead to an increase in fibril formation (17, 18). As electrophysiological abnormalities have been described even in embryonic
and early postnatal neurons cultured from mouse models of HD
(55, 56), well before inclusion bodies are deposited, these results
suggest that oligomer formation likely predominates during
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early stages of disease, whereas fibril formation may only occur
at later stages and may in fact represent a coping response. We
speculate that the striking susceptibility of medium spiny striatal neurons to the effects of mutant htt and even the cell-to-cell
variability observed among these cells may simply be explained
by their differential ability to degrade mutant htt or shuttle it
into an inclusion body and concomitant effects on the types of
toxic conformers that may accumulate at different protein concentrations in cellular microenvironments.
Understanding if different aggregate species relate to polyQ
length in some manner could help in identifying the conformers that mediate pathogenesis in HD. A systematic analysis of
the heterogeneous mix of mutant htt aggregates and the elucidation of the dependence of polyQ length on this process in vivo
may ultimately elicit the design of potential therapeutics (such
as intrabodies) to neutralize toxic mutant htt assemblies (57).
However, without precise knowledge of what constitutes a
toxic conformer in vivo, steps to alter aggregation or deplete
specific conformers could also potentially result in detrimental
effects. For example, an intrabody specific for the N terminus of
htt (VL12.3) had varying effects in different mouse models of
HD ranging from being beneficial in a lentiviral model of HD to
exacerbating phenotypes in the R6/2 HD model (57). In contrast, treatment with an intrabody specific for the polyproline
and proline-rich domains of Htt (Happ1) conferred beneficial
effects on several mouse models (57). As cellular dysfunction
and toxicity could lie in the balance between fibrillar and diffuse
forms of mutant htt, the risk/benefit ratio of therapies designed
to modulate aggregation might depend critically on the extent
to which the relative ratio of monomeric/oligomeric/fibrillar
aggregates is altered. Clearly, the polyQ repeat in mutant htt
can adopt multiple monomeric (41) and higher order conformations (21), of which only a subset may mediate pathogenesis
in HD. Although we found that mixtures of aggregates are quite
heterogeneous even with purified proteins, our data also indicates that this complexity is even greater in the crowded environment of the cytosol and nucleus of vulnerable neurons. To
understand which mutant htt species are toxic entities, the
major challenge will be to develop novel experimental tools
capable of identifying and quantifying specific conformers in
vivo in a highly sensitive manner. To this end, conformational
specific antibodies (22, 58, 23) appear to have great potential in
probing the complex diffuse fraction of mutant htt.
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